SYNYOUNG BIOMEDICS

Synyoung Biomedics specializes in the manufacturing and supply of in-vitro diagnostic reagents for blood gas analysis systems, serving critical military medical operations. The company provides clinically validated reagent kits and consumables compatible with Radiometer analyzers, ensuring precise, real-time patient monitoring in field and hospital settings. Their technical expertise lies in the formulation, quality control, and regulatory-compliant production of assay-specific reagents, with demonstrated experience in sustaining long-term supply chains for life-critical diagnostic instruments used in trauma, ICU, and expeditionary care environments. A key differentiator is their ability to manage reagent lifecycle modifications, including option exercises and fund reallocations, indicating deep integration with military logistics and procurement workflows. The contractor maintains a consistent relationship with the Department of Defense, delivering diagnostic reagents that support operational readiness across combat medics, field hospitals, and naval medical units. Their work directly enables point-of-care testing capabilities in austere environments, reinforcing DoD’s emphasis on autonomous, rapid diagnostic systems for deployed forces. Synyoung Biomedics operates primarily within NAICS 325413, focusing on the industrial-scale production of diagnostic substances for clinical instrumentation. This positions them as a niche supplier in the medical device consumables market, specifically serving the high-reliability segment required for defense and emergency medical applications. Their vertical specialization in blood gas reagents reflects a targeted market focus on analyte-specific chemistry for critical care diagnostics. As a 2L entity based in Seoul, Synyoung Biomedics operates as a non-U.S.-based supplier with no disclosed government certifications. Their geographic presence underscores a global supply chain role, providing specialized diagnostic materials to U.S. defense medical systems without domestic manufacturing footprint or federal small business status.